Drug-coated technology in PAD: The ESVS guidelines edition, part two

In second instalment of a Charing Cross (CX) Symposium roundtable discussion on the use of drug-based technology use in the lower extremity, Peter Schneider (University of California, San Francisco, USA) is joined by Sabine Steiner (Vienna, Austria), Mårten Falkenberg (Sahlgrenska University Hospital and the University of Gothenburg, Gothenberg, Sweden) and Koen Deloose (AZ Sint-Blasius Hospital, Dendermonde, Belgium) dig deeper into the role of the SWEDEPAD 2 trial results in the recent European Society for Vascular Surgery (ESVS) updated recommendations on the management of asymptomatic peripheral arterial disease (PAD) and intermittent claudication.